1989
DOI: 10.1097/00006250-198906000-00019
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Cyproterone Acetate and Danazol in the Treatment of Pelvic Pain Associated With Endometriosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
12
0
6

Year Published

1991
1991
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(19 citation statements)
references
References 0 publications
1
12
0
6
Order By: Relevance
“…Cyproterone acetate, a progestin with antiandrogenic activity, was given in combination with 0.035 mg ethinyl estradiol to 11 women in a comparison study with 600 mg/day danazol given to 12 women. 16 Treatment was carried out for 6 months. Diagnostic laparoscopy was performed in subjects prior to medication; no mention was made of surgical therapy at the time of laparoscopy.…”
Section: Progestins and Oral Contraceptivesmentioning
confidence: 99%
See 1 more Smart Citation
“…Cyproterone acetate, a progestin with antiandrogenic activity, was given in combination with 0.035 mg ethinyl estradiol to 11 women in a comparison study with 600 mg/day danazol given to 12 women. 16 Treatment was carried out for 6 months. Diagnostic laparoscopy was performed in subjects prior to medication; no mention was made of surgical therapy at the time of laparoscopy.…”
Section: Progestins and Oral Contraceptivesmentioning
confidence: 99%
“…Vercellini's group 10 used the same cyclic ethinyl estradiol/ desogestrel-containing oral contraceptive with a 50 mg/day dose of danazol in comparison with depot MPA. Fedele's group 16 compared danazol with the combination of cyproterone acetate and ethinyl estradiol, which is marketed in some countries as an oral contraceptive but is dissimilar to oral contraceptives available in the United States. Taking all three of these studies together, oral contraceptive-containing regimens may be comparable to depot MPA and to GnRH analog therapy.…”
Section: Progestins and Oral Contraceptivesmentioning
confidence: 99%
“…L'effet potentiellement réversible du traitement médical sur la douleur est expliqué par un effet suppressif et non pas curatif au niveau des implants (NP3) [27]. L'effet suppressif peut être maintenu pendant la durée du traitement, mais les symptômes douloureux peuvent réapparaître dans les mois suivant l'arrêt du traitement [22,28]. Le traitement médical a un effet suppressif sur les douleurs (grade A).…”
Section: Efficacité Des Traitements Médicaux Sur Les Douleurs D'endomunclassified
“…Porém, mais estudos devem ser realizados para defi nir sua utilização em pacientes com dor pélvica e endometriose 41,42 . Outras vias de administração de progestáge-nos têm sido testadas, como implante subdérmico de etonorgestrel e o sistema intra-uterino com liberação lenta de levonorgestrel (SIU-LNG).…”
Section: Progestágenos E Contraceptivos Orais Combinadosunclassified